RECOMBINANT APOLIPOPROTEIN – A NEW CLINICAL AGENT

Recent research demonstrate recombinant apolipoprotein, a carefully manufactured type of APO, presents a potential clinical approach for addressing multiple disease situations. This unique agent functions by selectively modulating fat processing and lowering inflammation, exhibiting substantial i